Search research articles
Contact Us
Filters
Showing results (1131-1140 of 1,245) with videos related to
Page
of 125
Sort By:
British Journal of Cancer
|
May 3, 2007
The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo
Y Akashi, I Okamoto, M Suzuki, et al.
Rheumatology (Oxford, England)
|
August 9, 2008
Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies
S Suzuki, T Satoh, S Sato, et al.
The Journal of Nihon University School of Dentistry
|
June 1, 1991
Basic studies on visible light-curing resin for denture base. Part 8. The hardening depth of denture relining material after penetration of light through the denture base resin
Y Aoyama, M Maeda, R Yokoi, et al.
Journal of Neurosurgery
|
February 1, 1990
Immunohistochemical demonstration of DNA polymerase alpha in human brain-tumor cells
K Kunishio, N Mishima, T Matsuhisa, et al.
The Journal of Antibiotics
|
June 1, 1991
Structural studies on avidinorubicin, a novel anthracycline with platelet aggregation inhibitory activity
M Aoki, H Shirai, N Nakayama, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics
|
May 1, 1990
[A case of multiple tumors]
H Chikazawa, J Shibata, H Murata, et al.
Biochemistry
|
May 28, 1996
NMR studies of the effects of the 5'-phosphate group on conformational properties of 5-methylaminomethyluridine found in the first position of the anticodon of Escherichia coli tRNA(Arg)4
K Sakamoto, G Kawai, S Watanabe, et al.
Carcinogenesis
|
December 1, 1995
Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)
M Hirose, R Hasegawa, J Kimura, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Treatment of hepatocellular carcinoma utilizing lymphokine-activated killer cells and interleukin-2
T Ichida, K Higuchi, K Arakawa, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1990
Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture
K Sato, T Satoh, K Shizume, et al.
Page
of 125
Search research articles
Search
Showing results (1131-1140 of 1,245) with videos related to
Sort By:
Page
of 125
British Journal of Cancer
|
May 3, 2007
The novel microtubule-interfering agent TZT-1027 enhances the anticancer effect of radiation in vitro and in vivo
Y Akashi, I Okamoto, M Suzuki, et al.
Rheumatology (Oxford, England)
|
August 9, 2008
Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies
S Suzuki, T Satoh, S Sato, et al.
The Journal of Nihon University School of Dentistry
|
June 1, 1991
Basic studies on visible light-curing resin for denture base. Part 8. The hardening depth of denture relining material after penetration of light through the denture base resin
Y Aoyama, M Maeda, R Yokoi, et al.
Journal of Neurosurgery
|
February 1, 1990
Immunohistochemical demonstration of DNA polymerase alpha in human brain-tumor cells
K Kunishio, N Mishima, T Matsuhisa, et al.
The Journal of Antibiotics
|
June 1, 1991
Structural studies on avidinorubicin, a novel anthracycline with platelet aggregation inhibitory activity
M Aoki, H Shirai, N Nakayama, et al.
Gan No Rinsho. Japan Journal of Cancer Clinics
|
May 1, 1990
[A case of multiple tumors]
H Chikazawa, J Shibata, H Murata, et al.
Biochemistry
|
May 28, 1996
NMR studies of the effects of the 5'-phosphate group on conformational properties of 5-methylaminomethyluridine found in the first position of the anticodon of Escherichia coli tRNA(Arg)4
K Sakamoto, G Kawai, S Watanabe, et al.
Carcinogenesis
|
December 1, 1995
Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)
M Hirose, R Hasegawa, J Kimura, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1989
Treatment of hepatocellular carcinoma utilizing lymphokine-activated killer cells and interleukin-2
T Ichida, K Higuchi, K Arakawa, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1990
Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture
K Sato, T Satoh, K Shizume, et al.
Page
of 125